Authors
Latest:
Enabling Evidence-Based Study Endpoint SelectionHarnessing advances in digital health technologies for a more precision-measured approach.
Latest:
Beyond the Checkbox: How Rethinking Your Cardiac Monitoring Approach Can Dramatically Improve Trial OutcomesAliveCor knows that cardiac safety is critical, with concerns often driving drug withdrawals from trials and the market. Our solutions go beyond compliance to boost regulatory trust, data integrity, and trial success. As the only company offering integrated 6L and 12L ECGs, we provide comprehensive monitoring—onsite and remotely—to meet complex cardiac requirements. Our innovative tools empower sponsors and CROs to control trial data, enabling faster, smarter decisions throughout the research lifecycle.
Latest:
Teamwork for Better Healthcare Solutions: Merging Clinical and Marketing EffortsIn the ever-evolving landscape of healthcare, it's vital for organizations to take steps toward bridging the gap between their clinical and marketing teams.
Latest:
Harnessing the Power of Scientific SurveillanceStatistical methods used via this technique in centralized monitoring.
Latest:
Oversight Method Identifies Critical Errors Missed by Traditional Monitoring ApproachesStudy Health Check provides early identification of issues related to protocol deviations and determines objective measures of site-specific versus study-wide performance.
Latest:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical TrialsStudy evaluates the use of AI-supported medical coding module.
Latest:
Orchestrating Different Levels of a Successful Clinical Study Start-UpSimilar to a world-class symphony, a curated site start-up model can accentuate its individual components and lead to swift starts for clinical trials.
Latest:
COVID-19: A New Era for Clinical Trial Research in Europe?A look at the issues in Europe affecting ongoing trials including data management, measures being taken by sponsors, and more.
Latest:
Implementing ePROs in Arthritis Clinical ResearchThe value of electronic patient-reported outcomes data in this disease setting.
Latest:
5 Strategies for Bridging the Sponsor-Site Tech DivideResults from survey of 100 site personnel suggest a disconnect is present between these stakeholders.
Latest:
Africa is Biosimulation’s Next FrontierThe answers to meeting biosimulation's growing demand for talent may lie in Africa.
Latest:
Regulatory CMC: Enhancing Biologics DevelopmentPreventing delays and accelerating the progression of these critical therapies.
Latest:
Using Digital Technology to Empower Patients and Restore TrustLooking at the road ahead to properly utilizing digital technology in clinical trials.
Latest:
The Impact of Decentralized and Hybrid Trials on Sponsor and CRO CollaborationsTufts CSDD study in collaboration with ten biopharmaceutical organizations and CROs examines sponsor/CRO relationships.
Latest:
COPD: Therapies on the CuspClinical trials in this area reflect new science, and corresponding challenges in their execution.
Latest:
Beyond the Black Box: Tailoring AI Regulation in HealthcareAs adoption increases, regulatory bodies are becoming more involved in the oversight of artificial intelligence.
Latest:
A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by GradeUsing existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.
Latest:
Evolving Tools and Perspectives for the Development of Cell and Gene TherapiesStakeholders must alter their mindsets when it comes to early-phase design and interpreting regulatory guidance for CGT trials.
Latest:
Streamlining Clinical Trials with eSource: Insights from MSKA use case by Memorial Sloan Kettering Cancer Center explores the potential of EHR-to-EDC.
Latest:
Self-collection of Blood Specimens in Clinical TrialsOperational and patient burden considerations for self-collection of blood specimens in clinical trials
Latest:
Cancer Won’t Wait for COVID to End: Conducting Trials Amid the Coronavirus PandemicThousands of trials have been halted as a consequence of the coronavirus pandemic, slowing the pace of scientific progress dramatically.
Latest:
5 Reasons Physicians Should Integrate Clinical Trials Into Their PracticeUsing IROs can offer the opportunity for doctors to incorporate clinical research as a care option in their practices.
